Back to BOURLIERE Marc

Marc BOURLIERE

Head of Hepato-Gastroenterology department

France

City: Marseille

Institution: Hopital Saint Joseph, Sce hépato gastro entérologie

Contact: mbourliere@hopital-saint-joseph.fr


Biography of Marc BOURLIERE

Marc Bourliere, received his medical degree in 1987 from Marseille University in Marseille, France. He completed his fellowship training at Marseille University hospital and in Beaujon University hospital in Paris. He was assistant in Hepatology in Conception University hospital in Marseille before taking up his current position as head of the Hepato-Gastroenterology department at Hospital Saint Joseph also in Marseille.

Dr Bourliere and his group have participated in hepatitis B and C and HCC clinical trials; His current research focus is the use and development of non invasive biomarkers in hepatitis and the development of new antiviral therapy for hepatitis C.

Dr Bourliere has published more than 190 papers or chapters in international journals and books focused on hepatitis B and C. As well as reviewing for many specialist journals, he has served as member of the editorial board of Gastroenterologie, Clinique et Biologique.

PHC's participations

Tuesday, March 28th 2023

INTRODUCTION (chairman)

Wednesday, March 29th 2023

CONCLUSION (chairman)

Monday, March 27th 2023

INTRODUCTION (chairman)

INTRODUCTION (chairman)

BEST POSTER PRIZE (chairman)

TAKE HOME MESSAGES DAY ONE (chairman) -

Wednesday, March 29th 2023

CONCLUSION (chairman)

Tuesday, March 09th 2021

INTRODUCTION (chairman)

INTRODUCTION (chairman)

AVANCEES DANS LE DIAGNOSTIC ET LE PRONOSTIC (chairman)

CONCLUSION (chairman)

IS ELIMINATION OF HCV BY 2030 REALISTIC (chairman)

TAKE HOME MESSAGES (chairman)

Immunotherapy combination: the revolution in unresectable HCC (chairman)

Monday, March 08th 2021

INTRODUCTION (chairman)

LESSONS FROM COVID-19 (chairman)

Welcome and Introduction

Simplified, decentralized care - how do DAAs make this feasible ?

Audience Q&A

Tuesday, January 14th 2020

Simplifying models of care to achieve HCV elimination (chairman)

13th PHC – 2020

Monday, January 13th 2020

TAKE HOME MESSAGES (chairman) -

12th PHC – 2019

Monday, January 14th 2019

HEPATITIS C - SESSION 1 (chairman)

Is DAA treatment failure still an issue? -

TAKE HOME MESSAGES (chairman) -

3rd PHC – 2009

Monday, January 19th 2009

(chairman)

4th PHC – 2011

Monday, January 17th 2011

New combinations (chairman)

5th PHC – 2012

Monday, January 30th 2012

Cirrhotics -

6th PHC – 2013

Monday, January 14th 2013

Cirrhotic patients -

7th PHC – 2014

Monday, January 13th 2014

Personalized treatment with boceprevir -

11th PHC – 2018

Monday, January 15th 2018

HEPATITIS C - SESSION 2 (chairman)

Take home messages (chairman) -

10th PHC – 2017

Monday, January 30th 2017

HEPATITIS C - SESSION 1 (chairman)

Take home messages (chairman) -

8th PHC – 2015

Monday, January 12th 2015

Genotype 2, what’s new? -

9th PHC – 2016

Monday, January 11th 2016

How to optimize therapy? (chairman)

New therapeutic strategies (chairman)

Tuesday, January 12th 2016

State of the art lecture (chairman) -

Lunch Workshops - Room 242A (chairman)

Take home message (chairman) -